Diagnosing the Unknown | GenomeWeb

Diagnosing the Unknown

Premium

As a clinician, Gauri Varadharachary has seen quite a few patients with metastatic tumors for which no amount of tests or imaging could determine the primary tumor site. If after CT scans, PSA testing, mammograms, and more targeted testing, the site still remains elusive, then the patients are diagnosed with carcinoma of unknown primary and are often treated with systemic chemotherapy instead of targeted therapies. Varadharachary, though, is working to change that by developing molecular-based methods to determine the origin of these types of tumors.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.